Results 41 to 50 of about 19,235 (204)

Efficacy of Contrast‐Enhanced Endoscopic Ultrasound in the Diagnosis of Gallbladder Tumor: A Retrospective Multicenter Cohort Study

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background and Aims Contrast‐enhanced endoscopic ultrasonography (CE‐EUS) provides clearer visualization of wall layer structures in gallbladder nodules than B‐mode EUS. This study aimed to compare the diagnostic performance of B‐mode EUS and CE‐EUS in differentiating benign from malignant gallbladder lesions.
Kensaku Yoshida   +7 more
wiley   +1 more source

Carcinosarcoma ex pleomorphic adenoma of the parotid gland: a case report [PDF]

open access: gold, 2021
Ali Almubarak   +4 more
openalex   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

open access: yesEuropean Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature

open access: yesCurrent Oncology, 2023
Colorectal carcinosarcoma is an exceedingly rare subtype of colorectal cancer that displays the histological and molecular features of both mesenchymal and epithelial tumors.
Changsu Lawrence Park   +3 more
doaj   +1 more source

Primary Peritoneal Carcinosarcoma: A Case Report [PDF]

open access: gold, 2021
Logan Erz   +3 more
openalex   +1 more source

Behind the scenes: how the EMILIN/Multimerin family shapes the cancer landscape

open access: yesThe FEBS Journal, EarlyView.
The EMILIN/Multimerin family members regulate key hallmarks of cancer—including apoptosis, angiogenesis, metastasis, and tumor microenvironment remodeling. As indicated, their function in immune evasion, drug resistance, and metabolic reprogramming remains largely unexplored.
Evelina Poletto   +9 more
wiley   +1 more source

Spotlight on Carcinosarcoma of the Ovary: A Scoping Review

open access: yesActa Medica
Ovarian carcinosarcoma, also referred as malignant mixed Mullerian tumour, is an uncommon, highly aggressive and malignant neoplasm which makes up 1 to 4% of all ovarian tumours.
Martina Gauci, Jean Calleja-Agius
doaj   +1 more source

Ovarian Teratoid Carcinosarcoma Is an Aggressive Tumor of Probable Mullerian Derivation with a Carcinosarcomatous and Mixed Germ-Cell Morphology

open access: yesCase Reports in Oncology, 2019
Ovarian carcinosarcoma is also referred to as malignant mixed Mullerian tumor (MMMT). It is a rare neoplasm, and although it represents less than 5% of malignant ovarian tumors, it remains generally well-known among clinicians and pathologists. Rarer yet
Courtney Fox   +3 more
doaj   +1 more source

Carcinosarcoma of the Maxillary Sinus [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2013
Carcinosarcoma is a highly malignant tumor characterized by dual malignant histologic differentiation of epithelial and mesenchymal components. The tumor is extremely rare in the sinonasal tract.
Jeong-Ki Moon   +3 more
doaj   +1 more source

Coordinated regulation of PIEZO2 by alternative splicing, post‐translational modification, membrane trafficking and protein partners

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Regulatory mechanisms such as alternative splicing, post‐translational modification, membrane trafficking, and protein interactions control channel gating, membrane abundance, and overall activity of PIEZO2. Proper regulation supports PIEZO2‐dependent proprioceptive, somatosensory, nociceptive, pruriceptive and interoceptive ...
Eunice I. Oribamise   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy